GlassScriptPhysician profile
Royce Lee Bargas
NPI 1013063635
$2,377.92
in general payments reported to CMS, 2019-2025
22 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $811 · 2021: $85.63 · 2022: $145 · 2023: $127 · 2024: $353 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,133.07 | 2019-2022 | |
| Boston Scientific Corporation | $180.50 | 2019-2025 | Watchman Flx, Bodyguardian, Cds - Mct/Cem Monitoring |
| E.R. Squibb & Sons, L.L.C. | $130.35 | 2025 | |
| Biosense Webster, INC. | $121.76 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $119.86 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $114.59 | 2024 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.10 | 2020-2021 | |
| Esperion Therapeutics, INC. | $71.53 | 2024-2025 | Nexletol |
| Cleerly, INC. | $59.61 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Medtronic Vascular, INC. | $58.29 | 2019 | |
| Merck Sharp & Dohme LLC | $57.37 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.05 | 2020-2023 | Jardiance |
| Novo Nordisk INC | $33.59 | 2021-2023 | Wegovy |
| Corcept Therapeutics | $29.02 | 2024 | Korlym |
| Kiniksa Pharmaceuticals International, Plc | $28.90 | 2024 | Arcalyst |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $18.17 | 2023 | NP Thyroid 60 |
| Eisai INC. | $18.01 | 2024 | |
| Sanofi-Aventis U.S. LLC | $16.31 | 2019 | |
| Preventice Services, LLC | $14.96 | 2021 | |
| Dexcom, INC. | $13.20 | 2022 | |
| Amarin Pharma, INC. | $12.42 | 2021 | |
| Allergan, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Royce Bargas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.